Your body will thank you for it
FDA-approved medication pathways require evaluation by licensed medical professionals
Notice of Compliance issued April 29, 2014 to Theratechnologies Inc
However, the seven peptides that will be under reviewBPC-157, TB-500, KPV, MOT-s, Semax, Epitalon and Emideltideoccupy a different category
The review confirmed BPC-157s angiomodulatory profile, noting that VEGF, Factor VIII, and CD34 peak in the early wound interval and that BPC-157 exhibits angiogenic effects exceeding those of standard agents in the sponge assay
Name CJC-1295 Concentration 5mg per vial Form Lyophilized powder Purity 99%, confirmed by HPLC and MS Packaging Sterile, sealed vial Storage -20C in a dark, dry environment Documentation Certificate of Analysis (COA) available upon request CJC-1295 is a synthetic peptide that acts as a Growth Hormone-Releasing Hormone (GHRH) analog